Back to the NHL Newsfeed

UK Gene Editing Market Impressive CAGR +14% by 2028| Caribou Biosciences, Sangamo, Editas Medicine, Recombinetics, Thermo Fisher Scientific, CRISPR THERAPEUTICS, Intellia Therapeutics, Sigma Aldrich Corporation

UK Gene Editing Market is projected to register a CAGR of +14% by the timeline of 2021-28.

The United Kingdom is considering innovative ways of regulating gene editing in food and farming. Robust processes and public confidence will be vital for success. The UK government has an opportunity to create a new system for regulating gene editing in food and agriculture that is scientifically sound. It must do so in a way that respects the independence of the regulatory process, because, among other things, that will be key to bringing the public with it.

Older gene-editing tools use proteins instead of RNA to target damaged genes.